Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;191(5):2367-2368.
doi: 10.1007/s11845-021-02820-y. Epub 2021 Oct 29.

Sars-Cov-2 and risk of antiviral drug resistance

Antonio Vitiello  1
Affiliations
Comment

Sars-Cov-2 and risk of antiviral drug resistance

Antonio Vitiello. Ir J Med Sci. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

Comment on

  • In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.
    Szemiel AM, Merits A, Orton RJ, MacLean OA, Pinto RM, Wickenhagen A, Lieber G, Turnbull ML, Wang S, Furnon W, Suarez NM, Mair D, da Silva Filipe A, Willett BJ, Wilson SJ, Patel AH, Thomson EC, Palmarini M, Kohl A, Stewart ME. Szemiel AM, et al. PLoS Pathog. 2021 Sep 17;17(9):e1009929. doi: 10.1371/journal.ppat.1009929. eCollection 2021 Sep. PLoS Pathog. 2021. PMID: 34534263 Free PMC article.

References

    1. World Health Organization (WHO) Coronavirus2019/situation-reports. Situation Reports. https://www.who.int/emergencies/diseases/novel september 2021
    1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9. - DOI - PMC - PubMed
    1. Vitiello A, Porta R, Pianesi L, Ferrara F. COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view. Ir J Med Sci. 2021 doi: 10.1007/s11845-021-02584-5. - DOI - PMC - PubMed
    1. Tarighi P, Eftekhari S, Chizari M, et al. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. Eur J Pharmacol. 2021;895:173890. doi: 10.1016/j.ejphar.2021.173890. - DOI - PMC - PubMed
    1. Duwe S. Influenza viruses — antiviral therapy and resistance. GMS Infect Dis. 2017;5(Doc04):20. - PMC - PubMed

Substances